arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Ginkgo Bioworks Holdings, Inc.

DNA Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$6.95
▼ -0.1% Today
as of Sep 4, 16:48 ET
Last 30 days -9.74% Jul 28 → Sep 04
$6.30 $7.13 $7.95 $8.77 $9.60 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$6.80
High
$6.97
Low
$6.74
Volume
$656,000
Avg Vol
$1M
Mkt Cap
$466M
P/E (TTM)
—
Beta
—
52w High
$17.58
52w Low
$5.37
Div Yield
—
Shares Out
$64M

Recent Press Releases & News last 60 days · 2 items

Aug 8 · 04:03 MarketBeat
Ginkgo Bioworks Q2 Earnings Call Highlights
Aug 7 · 04:19 Moby
Ginkgo Bioworks Holdings, Inc. Q2 2026 Earnings Call Summary

Overview

52-week range
$5.37
$18
13% of range
Avg surprise (last 2)
-2.4%
Avg reaction (last 2)
-2.2%
50% positive
Latest IV / EM
87%
EM ±13.7% · $7 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-6.21$-4.68$-3.15$-1.62$-0.09 Actual $-0.11Actual $-0.09Actual $-6.21Actual $-3.32Actual $-4.23Actual $-1.08Actual $-1.58Est $-1.23Actual $-1.10Est $-1.44Actual $-1.45Actual $-1.28 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026
Revenue vs Net Income Revenue Net income
$-91M$-45M$1M$47M$93M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-1.28 — — +19.0% +2.4% earnings
Tue Sep 30, 2025Sep 2025 $-1.45 — — — — financials
Thu Aug 7, 2025Jun/2025 $-1.10 $-1.44 +23.6% — — earnings
Tue May 6, 2025Mar/2025 $-1.58 $-1.23 -28.5% — -6.8% earnings
Mon Sep 30, 2024Sep 2024 $-1.08 — — — — financials
Sun Jun 30, 2024Jun 2024 $-4.23 — — — — financials
Sun Mar 31, 2024Mar 2024 $-3.32 — — — — financials
Sat Sep 30, 2023Sep 2023 $-6.21 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.09 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.11 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$20M$19M—$39M$39M$38M—$89M
Cost of revenue$2M$3M——$5M$4M——
Gross profit————————
Operating income$-59M$-71M—$-90M$-58M$-81M—$-55M
Net income$-47M$-83M—$-81M$-60M$-91M—$-56M
EPS (diluted)———$-1.45$-1.10$-1.68—$-1.08

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$85M$144M$167M$111M$204M$312M$562M$616M
Inventory————————
Total current assets$333M$410M$472M$506M$523M$565M$603M$662M
Total assets$990M$1.03B$1.12B$1.19B$1.23B$1.29B$1.38B$1.48B
Long-term debt————————
Total liabilities$570M$590M$611M$629M$618M$646M$661M$683M
Total equity$420M$443M$509M$560M$613M$647M$716M$798M

Implied volatility — last 90 days

82%126%171%215%259% Jun 07 — IV 132% · EM ±18.2%Jun 08 — IV 115% · EM ±15.1%Jun 09 — IV 113% · EM ±14.1%Jun 10 — IV 120% · EM ±14.2%Jun 11 — IV 119% · EM ±13.1%Jun 12 — IV 102% · EM ±10.5%Jun 15 — IV 109% · EM ±7.9%Jun 16 — IV 129% · EM ±7.6%Jun 17 — IV 210% · EM ±8.8%Jun 19 — IV 95% · EM ±21.0%Jun 22 — IV 98% · EM ±20.5%Jun 23 — IV 94% · EM ±19.2%Jun 24 — IV 105% · EM ±21.1%Jun 25 — IV 96% · EM ±18.8%Jun 26 — IV 94% · EM ±18.0%Jun 29 — IV 100% · EM ±17.6%Jun 30 — IV 101% · EM ±17.4%Jul 01 — IV 102% · EM ±17.0%Jul 02 — IV 97% · EM ±15.6%Jul 03 — IV 98% · EM ±15.4%Jul 06 — IV 107% · EM ±14.8%Jul 07 — IV 96% · EM ±12.7%Jul 08 — IV 108% · EM ±13.5%Jul 09 — IV 109% · EM ±12.9%Jul 10 — IV 109% · EM ±12.1%Jul 13 — IV 107% · EM ±9.0%Jul 14 — IV 130% · EM ±9.4%Jul 15 — IV 136% · EM ±8.1%Jul 16 — IV 260% · EM ±10.9%Jul 20 — IV 114% · EM ±26.8%Jul 21 — IV 108% · EM ±25.0%Jul 22 — IV 102% · EM ±23.4%Jul 23 — IV 118% · EM ±26.5%Jul 24 — IV 129% · EM ±28.5%Jul 27 — IV 154% · EM ±32.2%Jul 28 — IV 124% · EM ±25.3%Jul 29 — IV 128% · EM ±25.6%Jul 30 — IV 118% · EM ±23.2%Jul 31 — IV 124% · EM ±23.8%Aug 03 — IV 134% · EM ±23.8%Aug 04 — IV 116% · EM ±20.0%Aug 05 — IV 131% · EM ±21.9%Aug 06 — IV 122% · EM ±19.8%Aug 07 — IV 100% · EM ±15.7%Aug 10 — IV 94% · EM ±13.1%Aug 11 — IV 146% · EM ±19.3%Aug 12 — IV 94% · EM ±11.8%Aug 13 — IV 94% · EM ±11.1%Aug 14 — IV 105% · EM ±11.6%Aug 17 — IV 83% · EM ±6.9%Aug 18 — IV 233% · EM ±16.8%Aug 19 — IV 137% · EM ±8.1%Aug 20 — IV 189% · EM ±7.9%Aug 24 — IV 82% · EM ±17.2%Aug 25 — IV 86% · EM ±17.6%Aug 26 — IV 93% · EM ±18.7%Aug 27 — IV 95% · EM ±18.6%Aug 28 — IV 88% · EM ±16.9%Aug 31 — IV 84% · EM ±14.8%Sep 01 — IV 90% · EM ±15.5%Sep 02 — IV 92% · EM ±15.3%Sep 03 — IV 87% · EM ±14.0%Sep 04 — IV 87% · EM ±13.7%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in